AMLX
Amylyx Pharmaceuticals Inc
30.10$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.0% | 12.5% | -0.6% | – | -9,992.8% | – | – | – | – | – | – | – | – | |
| 0.3% | 0.3% | 0.4% | – | 53.1% | – | – | – | – | – | – | – | – | |
| 9.9% | 8.8% | 11.2% | – | 1,635.3% | – | – | – | – | – | – | – | – | |
| -33.2% | 1.4% | 0.2% | – | -2,547.4% | – | – | – | – | – | – | – | – | |
| 0.3% | 0.3% | 0.1% | – | 4.6% | – | – | – | – | – | – | – | – | |
| -105.3% | 19.3% | 0.9% | – | 9,330.8% | – | – | – | – | – | – | – | – | |
| -0.1% | -0.1% | -1.5% | – | 320.9% | – | – | – | – | – | – | – | – | |
| 0.9% | 0.2% | 0.1% | – | 19.2% | – | – | – | – | – | – | – | – | |
| -109.6% | 32.2% | 0.4% | – | -586.1% | – | – | – | – | – | – | – | – | |
| -5.4% | 12.2% | -0.6% | – | -9,988.2% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.